This mechanism was initially developed to manage blood sugar levels in people with type 2 diabetes, as GLP-1 also stimulates insulin secretion in response to glucose
Formulated with Copper Peptides, a multi-peptide complex, Triple Hyaluronic Acid, and Squalane, this lightweight gel serum helps improve the look of elasticity, smoother-looking texture, and hydrated skin without leaving a heavy finish
With the full Phase 1 maintenance trial data, likely reported in Q326, this will provide additional de-risking (if data is positive), allowing a potential re-sizing, as the Phase 3 trial data grows closer
Research specific compatibility before mixing any peptides
This metabolic improvement occurs through AMPK pathway activation and increased NAD+-dependent SIRT1 activity, both of which enhance insulin receptor signaling and glucose metabolism
additional contraceptive methods are advised for 4 weeks after starting treatment and after each dose increase Patients with severe gastrointestinal disease (e.g., gastroparesis) should generally avoid Mounjaro If the patient is on insulin, doses should not be rapidly reduced when starting Mounjaro, as this increases the risk of diabetic ketoacidosis Patients should be counselled to report symptoms suggestive of thyroid C-cell tumours (neck mass, difficulty swallowing, persistent hoarseness) A collaborative approach involving endocrinologists, GPs, and diabetes specialists is often beneficial to ensure comprehensive care and monitoring
